AstraZeneca Pharma India (NSE:ASTRAZEN) Cash per Share : ₹0.00 (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). AstraZeneca Pharma India's Cash per Share for the quarter that ended in Dec. 2024 was ₹0.00.

AstraZeneca Pharma India Cash per Share Historical Data

The historical data trend for AstraZeneca Pharma India's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Cash per Share Chart

AstraZeneca Pharma India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash per Share

Get a 7-Day Free Trial

101.00

140.94

179.37

200.14

202.23

AstraZeneca Pharma India Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash per Share	Get a 7-Day Free Trial															-	202.23	-	203.19	-

AstraZeneca Pharma India Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

AstraZeneca Pharma India's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	5055.7	/	25
	=	202.23

AstraZeneca Pharma India's Cash per Share for the quarter that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0	/	25
	=	0.00

AstraZeneca Pharma India (NSE:ASTRAZEN) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

AstraZeneca Pharma India Cash per Share Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (NSE:ASTRAZEN) » Definitions » Cash per Share

Traded in Other Exchanges

506820:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines.

AstraZeneca Pharma India Headlines

No Headlines